[144] New York Times Co. SEC Filing
Rhea-AI Filing Summary
Form 144 filed for The New York Times Company (NYT) reports a proposed sale of 5,500 Class A shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $330,220 and total shares outstanding listed as 162,038,098. The shares were acquired via restricted stock vesting on dates between 02/18/2023 and 02/18/2025 in five tranches totaling 5,500 shares, and no shares were reported sold in the past three months. The filer certifies they are unaware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice — modest size relative to company float; not materially informative on operations.
The Form 144 documents a planned open-market sale of 5,500 Class A shares valued at $330,220. Given the issuer's reported outstanding share count of 162,038,098, the position represents a negligible fraction of total shares. The securities were acquired through restricted stock vesting across 2023–2025, indicating compensation-related origin rather than an external purchase. There are no reported sales in the prior three months and no additional disclosures of material events, so the filing is a routine compliance notice with limited direct implications for NYT's financial results or valuation.
TL;DR: Disclosure aligns with Rule 144 requirements; vesting-origin shares and certification suggest standard insider compliance.
The notice identifies the seller's shares as resulting from restricted stock vesting, and the signer affirms no undisclosed material adverse information. The use of a brokerage firm and a specified approximate sale date satisfies customary procedural expectations for planned insider disposals. Absence of sales in the prior three months reduces aggregation concerns under Rule 144(e). From a governance standpoint, the filing reflects standard insider reporting rather than any governance red flag.